SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
2018
|
| Subjects: | |
| Online Access: | Volltext Volltext Volltext |
| Physical Description: | 1 Online-Ressource |
| Format: | Langzeitarchivierung gewährleistet, LZA |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044751293 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 180207s2018 gw |||| o||u| ||||||eng d | ||
| 015 | |a 18,O02 |2 dnb | ||
| 016 | 7 | |a 1151399817 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-93293 |2 urn | |
| 035 | |a (OCoLC)1024126784 | ||
| 035 | |a (DE-599)DNB1151399817 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 100 | 1 | |a Karg, M. V. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a SGLT-2-inhibition with dapagliflozin reduces tissue sodium content |b a randomised controlled trial |c M. V. Karg, A. Bosch, D. Kannenkeril, K. Striepe, C. Ott, M. P. Schneider, F. Boemke-Zelch, P. Linz, A. M. Nagel, J. Titze, M. Uder, R. E. Schmieder |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |c 2018 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 538 | |a Langzeitarchivierung gewährleistet, LZA | ||
| 653 | |a Magnetic resonance imaging | ||
| 653 | |a Type 2 diabetes | ||
| 653 | |a SGLT-2 inhibition | ||
| 653 | |a Tissue sodium content | ||
| 700 | 1 | |a Bosch, A. |e Verfasser |4 aut | |
| 700 | 1 | |a Kannenkeril, D. |e Verfasser |4 aut | |
| 700 | 1 | |a Striepe, K. |e Verfasser |4 aut | |
| 700 | 1 | |a Ott, C. |e Verfasser |4 aut | |
| 700 | 1 | |a Schneider, M. P. |e Verfasser |4 aut | |
| 700 | 1 | |a Boemke-Zelch, F. |e Verfasser |4 aut | |
| 700 | 1 | |a Linz, P. |e Verfasser |4 aut | |
| 700 | 1 | |a Nagel, A. M. |e Verfasser |4 aut | |
| 700 | 1 | |a Titze, J. |e Verfasser |4 aut | |
| 700 | 1 | |a Uder, M. |e Verfasser |4 aut | |
| 700 | 1 | |a Schmieder, R. E. |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t Cardiovascular Diabetology |g Vol. 17 (2018) |o 10.1186/s12933-017-0654-z |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-93293 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1151399817/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/9329 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030146940 | ||
Record in the Search Index
| _version_ | 1804178264171741184 |
|---|---|
| any_adam_object | |
| author | Karg, M. V. Bosch, A. Kannenkeril, D. Striepe, K. Ott, C. Schneider, M. P. Boemke-Zelch, F. Linz, P. Nagel, A. M. Titze, J. Uder, M. Schmieder, R. E. |
| author_facet | Karg, M. V. Bosch, A. Kannenkeril, D. Striepe, K. Ott, C. Schneider, M. P. Boemke-Zelch, F. Linz, P. Nagel, A. M. Titze, J. Uder, M. Schmieder, R. E. |
| author_role | aut aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Karg, M. V. |
| author_variant | m v k mv mvk a b ab d k dk k s ks c o co m p s mp mps f b z fbz p l pl a m n am amn j t jt m u mu r e s re res |
| building | Verbundindex |
| bvnumber | BV044751293 |
| collection | ebook |
| ctrlnum | (OCoLC)1024126784 (DE-599)DNB1151399817 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02172nmm a2200541zc 4500</leader><controlfield tag="001">BV044751293</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180207s2018 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">18,O02</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1151399817</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-93293</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1024126784</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1151399817</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Karg, M. V.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">SGLT-2-inhibition with dapagliflozin reduces tissue sodium content</subfield><subfield code="b">a randomised controlled trial</subfield><subfield code="c">M. V. Karg, A. Bosch, D. Kannenkeril, K. Striepe, C. Ott, M. P. Schneider, F. Boemke-Zelch, P. Linz, A. M. Nagel, J. Titze, M. Uder, R. E. Schmieder</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Langzeitarchivierung gewährleistet, LZA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Magnetic resonance imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Type 2 diabetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SGLT-2 inhibition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Tissue sodium content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bosch, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kannenkeril, D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Striepe, K.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ott, C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schneider, M. P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boemke-Zelch, F.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Linz, P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagel, A. M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Titze, J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Uder, M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmieder, R. E.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Cardiovascular Diabetology</subfield><subfield code="g">Vol. 17 (2018)</subfield><subfield code="o">10.1186/s12933-017-0654-z</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-93293</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1151399817/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/9329</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030146940</subfield></datafield></record></collection> |
| id | DE-604.BV044751293 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:01:12Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030146940 |
| oclc_num | 1024126784 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
| record_format | marc |
| spelling | Karg, M. V. Verfasser aut SGLT-2-inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial M. V. Karg, A. Bosch, D. Kannenkeril, K. Striepe, C. Ott, M. P. Schneider, F. Boemke-Zelch, P. Linz, A. M. Nagel, J. Titze, M. Uder, R. E. Schmieder Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) 2018 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Langzeitarchivierung gewährleistet, LZA Magnetic resonance imaging Type 2 diabetes SGLT-2 inhibition Tissue sodium content Bosch, A. Verfasser aut Kannenkeril, D. Verfasser aut Striepe, K. Verfasser aut Ott, C. Verfasser aut Schneider, M. P. Verfasser aut Boemke-Zelch, F. Verfasser aut Linz, P. Verfasser aut Nagel, A. M. Verfasser aut Titze, J. Verfasser aut Uder, M. Verfasser aut Schmieder, R. E. Verfasser aut Sonderdruck aus Cardiovascular Diabetology Vol. 17 (2018) 10.1186/s12933-017-0654-z https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-93293 Resolving-System kostenfrei Volltext http://d-nb.info/1151399817/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/9329 Verlag kostenfrei Volltext |
| spellingShingle | Karg, M. V. Bosch, A. Kannenkeril, D. Striepe, K. Ott, C. Schneider, M. P. Boemke-Zelch, F. Linz, P. Nagel, A. M. Titze, J. Uder, M. Schmieder, R. E. SGLT-2-inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial |
| title | SGLT-2-inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial |
| title_auth | SGLT-2-inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial |
| title_exact_search | SGLT-2-inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial |
| title_full | SGLT-2-inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial M. V. Karg, A. Bosch, D. Kannenkeril, K. Striepe, C. Ott, M. P. Schneider, F. Boemke-Zelch, P. Linz, A. M. Nagel, J. Titze, M. Uder, R. E. Schmieder |
| title_fullStr | SGLT-2-inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial M. V. Karg, A. Bosch, D. Kannenkeril, K. Striepe, C. Ott, M. P. Schneider, F. Boemke-Zelch, P. Linz, A. M. Nagel, J. Titze, M. Uder, R. E. Schmieder |
| title_full_unstemmed | SGLT-2-inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial M. V. Karg, A. Bosch, D. Kannenkeril, K. Striepe, C. Ott, M. P. Schneider, F. Boemke-Zelch, P. Linz, A. M. Nagel, J. Titze, M. Uder, R. E. Schmieder |
| title_short | SGLT-2-inhibition with dapagliflozin reduces tissue sodium content |
| title_sort | sglt 2 inhibition with dapagliflozin reduces tissue sodium content a randomised controlled trial |
| title_sub | a randomised controlled trial |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-93293 http://d-nb.info/1151399817/34 https://open.fau.de/handle/openfau/9329 |
| work_keys_str_mv | AT kargmv sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT boscha sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT kannenkerild sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT striepek sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT ottc sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT schneidermp sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT boemkezelchf sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT linzp sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT nagelam sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT titzej sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT uderm sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial AT schmiederre sglt2inhibitionwithdapagliflozinreducestissuesodiumcontentarandomisedcontrolledtrial |